Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Amyl Nitrite Inhalant
Active Ingredient: Amyl nitrite 98%w/v
Dosage Form: Volatile liquid for inhalation
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: James Alexander Corporation, Blairstown, New Jersey, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 1st day of August 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).